OMB control number

Expedited Programs for Serious Conditions-Drugs and Biologics

OMB 0910-0765 · HHS/FDA.

OMB 0910-0765

This ICR collects information from sponsors and applicants who wish to obtain a priority review designation or breakthrough therapy designation. Respondents to the collection are manufacturers or sponsors of drug and/or biologic products.

The latest form for Expedited Programs for Serious Conditions-Drugs and Biologics expires 2028-03-31 and can be found here.

OMB Details

Priority Review Designation Requests (Expedited Programs for Serious Conditions) - CDER

Federal Enterprise Architecture: Health - Consumer Health and Safety